Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial
If you want a longer track record, slightly lower cost, and pill options, Semaglutide might be your match
This often results in shortages
Oral BPC-157 for Gastrointestinal Conditions Injectable BPC-157 for Musculoskeletal Conditions Injection Technique and Patient Education All patients receiving injectable BPC-157 are provided with: Detailed written instructions for reconstitution, storage, and administration In-person or video training on proper subcutaneous injection technique Sharps disposal containers and guidance on safe disposal 24-hour clinical contact for questions or concerns Most patients self-administer injections after the first week of supervised dosing
(Its sibling product, Wegovy, contains the same semaglutide but is approved specifically for chronic weight management.) That appetite-taming, stomach-slowing action is exactly why semaglutide is so effective and also why it produces gastrointestinal side effects in some people
While licensed in the UK, it is not routinely commissioned in many NHS areas and availability varies by local formulary decisions